All Stories

UPDATE: Merck KGaA sets its sights on acquisition of Ogsiveo maker SpringWorks

Merck KGaA is in advanced talks to acquire cancer and rare disease specialist SpringWorks, which has a market value of around $3 billion, Reuters reported Monday. Merck KGaA confirmed the talks but said it's not certain a deal will come together.

Feb 11, 2025 - 16:41
 0
UPDATE: Merck KGaA sets its sights on acquisition of Ogsiveo maker SpringWorks
Merck KGaA is in advanced talks to acquire cancer and rare disease specialist SpringWorks, which has a market value of around $3 billion, Reuters reported Monday. Merck KGaA confirmed the talks but said it's not certain a deal will come together.
Read More

Tags:

Previous Article

Mugler Fragrances Taps Cai Xukun as Global Ambassador

Next Article

Greenpeace sues US energy group in test of new EU freedom of speech rules

Related Posts

Chiesi unveils €430M investment to revitalize Italian production site for inhaler, biologics manufacturing

Chiesi unveils €430M investment to revitalize Italian p...

Mar 27, 2025  0

Bayer CEO Bill Anderson took pay cut in 2024 as company kicked off 3-year restructuring

Bayer CEO Bill Anderson took pay cut in 2024 as company...

Mar 7, 2025  0

Canada locks down an initial 500K doses of GSK's bird flu vaccine

Canada locks down an initial 500K doses of GSK's bird f...

Feb 20, 2025  0